MiMedX
Headquartered in Marietta, Georgia, MiMedX is a therapeutic biologics company committed to advanced wound care. They develop and distribute human, placental-based tissue allographs to treat patients with chronic or hard-to-heal injuries.
MiMedX joined the RegenMed Hub as part of the Innovation Accelerator in 2022 and will continue development in regenerative biomaterial products and bioimplants to help those suffering from chronic wounds or disease.